Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matthias Lőhr"'
Autor:
Cory Perugino, Emma L. Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, Nicolas Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H. Stone
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1795-1808 (2023)
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a debilitating multiorgan disease characterized by recurring flares leading to organ dysfunction, decreased quality of life, and mortality. Glucocorticoids, the standard of care for
Externí odkaz:
https://doaj.org/article/8fd489c2c4564ecf821166afa716dc2e
Autor:
Mathias E. Cook, Cecilie S. Knoph, Camilla A. Fjelsted, Jens B. Frøkjær, Anders E. Bilgrau, Srdan Novovic, Maiken Thyregod Jørgensen, Michael B. Mortensen, Liv B. J. Nielsen, Amer Hadi, Mark Berner-Hansen, Wiktor Rutkowski, Miroslav Vujasinovic, Matthias Löhr, Asbjørn M. Drewes, Søren S. Olesen
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Acute and chronic pancreatitis constitute a continuum of inflammatory disease of the pancreas with an increasing incidence in most high-income countries. A subset of patients with a history of pancreatitis suffer from recurrence o
Externí odkaz:
https://doaj.org/article/51ccbbb22fc14f1c96c466eef9a594fd
Autor:
Negar Abbasi Aval, Ekeram Lahchaichi, Oana Tudoran, Farzaneh Fayazbakhsh, Rainer Heuchel, Matthias Löhr, Torbjörn Pettersson, Aman Russom
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3061 (2023)
Three-dimensional (3D) tumor spheroids are regarded as promising models for utilization as preclinical assessments of chemo-sensitivity. However, the creation of these tumor spheroids presents challenges, given that not all tumor cell lines are able
Externí odkaz:
https://doaj.org/article/e1b8b66f39a349d582a1738207a46069
Autor:
Marianna Vitaloni PhD, Patrick Michl MD, Matthias Löhr MD, PhD, Ali Stunt PhD, Patrycja Rzadkowska MA, Eva Backman BA, Lama Sharara PhD, Vitor Neves, Thomas Gruenberger MD, Zorana Maravic MBA, BSc
Publikováno v:
Journal of Patient Experience, Vol 9 (2022)
Pancreatic cancer is a disease requiring urgent attention from governments and policymakers. Recently, a state of emergency has been declared for this cancer—being the fourth most common cause of cancer deaths in the European Union, it has the lowe
Externí odkaz:
https://doaj.org/article/64a1bac1461147398c71652cc8dbdf72
Autor:
Evangelina López de Maturana, Juan Antonio Rodríguez, Lola Alonso, Oscar Lao, Esther Molina-Montes, Isabel Adoración Martín-Antoniano, Paulina Gómez-Rubio, Rita Lawlor, Alfredo Carrato, Manuel Hidalgo, Mar Iglesias, Xavier Molero, Matthias Löhr, Christopher Michalski, José Perea, Michael O’Rorke, Victor Manuel Barberà, Adonina Tardón, Antoni Farré, Luís Muñoz-Bellvís, Tanja Crnogorac-Jurcevic, Enrique Domínguez-Muñoz, Thomas Gress, William Greenhalf, Linda Sharp, Luís Arnes, Lluís Cecchini, Joaquim Balsells, Eithne Costello, Lucas Ilzarbe, Jörg Kleeff, Bo Kong, Mirari Márquez, Josefina Mora, Damian O’Driscoll, Aldo Scarpa, Weimin Ye, Jingru Yu, PanGenEU Investigators, Montserrat García-Closas, Manolis Kogevinas, Nathaniel Rothman, Debra T Silverman, SBC/EPICURO Investigators, Demetrius Albanes, Alan A Arslan, Laura Beane-Freeman, Paige M Bracci, Paul Brennan, Bas Bueno-de-Mesquita, Julie Buring, Federico Canzian, Margaret Du, Steve Gallinger, J Michael Gaziano, Phyllis J Goodman, Marc Gunter, Loic LeMarchand, Donghui Li, Rachael E Neale, Ulrika Peters, Gloria M Petersen, Harvey A Risch, Maria José Sánchez, Xiao-Ou Shu, Mark D Thornquist, Kala Visvanathan, Wei Zheng, Stephen J Chanock, Douglas Easton, Brian M Wolpin, Rachael Z Stolzenberg-Solomon, Alison P Klein, Laufey T Amundadottir, Marc A Marti-Renom, Francisco X Real, Núria Malats
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-18 (2021)
Abstract Background Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic var
Externí odkaz:
https://doaj.org/article/fd82873a71df49c79bdc3dadb14c043b
Autor:
Carlos Fernández Moro, Matthias Löhr, Fei He, Dhifaf Sarhan, Marit Melssen, Ahmed Calandigary, Enana Malki, Marina Kaisso, Peter Olofsson-Sahl, Mikael Karlsson, Rainer Heuchel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/fdc57e45efa14403bd7847f6310852a0
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most overlooked cancers despite its dismal median survival time of 6 months. The biggest challenges in improving patient survival are late diagnosis due to lack of diagnostic markers, and limited
Externí odkaz:
https://doaj.org/article/e8606bec19f644059c1b60401dbb1227
Autor:
Xinyuan Liu, Beate Gündel, Xidan Li, Jianping Liu, Anthony Wright, Matthias Löhr, Gustav Arvidsson, Rainer Heuchel
Publikováno v:
Translational Oncology, Vol 14, Iss 7, Pp 101107- (2021)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, partly due to the dense desmoplasia and a lack of suitable model systems to study. In the present work, we developed a 3D heterospecies spheroid model to study the microe
Externí odkaz:
https://doaj.org/article/15f198d3d0964cc085088e9a0ad7945e
Autor:
Marcus Reuterwall, Jeanne Lubbe, Lars Enochsson, Lars Lundell, Magnus Konradsson, Frederik Swahn, Marco Del Chiaro, Matthias Löhr, Urban Arnelo
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Single-operator, per-oral cholangiopancreatoscopy (SOPCP) enables direct biliopancreatic ductal visualization, targeted tissue sampling, and therapeutic intervention. At Karolinska University Hospital, SOPCP was introduced early a
Externí odkaz:
https://doaj.org/article/cda8b3e1949a472ab430f08fa4a02b60
Autor:
Marco Lanzillotta, Olof Vinge-Holmquist, Kasper A. Overbeek, Jakob L. Poulsen, A. Fatih Demirci, Peter Macinga, Matthias Löhr, Jonas Rosendahl
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Introduction: Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centers, and largely depend on the experience of the physi
Externí odkaz:
https://doaj.org/article/163386b8f69f4961b563869fcde1aab6